{ "@context": "https://schema.org", "@type": "Dataset", "name": "Boise Standard Entity: rapalimus-gel.nobelpark.jp", "url": "https://boisestandard.org/web/rapalimus-gel-nobelpark-jp", "identifier": "bs-c7d51130", "datePublished": "2026-07-03T14:57:01.936363+00:00", "description": "Boise Standard machine-readable entity profile for rapalimus-gel.nobelpark.jp. Schema.org coverage graph, six-layer topology fingerprint, ratio signals, Root-LD anchor. Full provenance.", "license": "https://creativecommons.org/publicdomain/zero/1.0/", "isAccessibleForFree": true, "creator": { "@type": "Organization", "name": "Boise Standard", "url": "https://boisestandard.org" }, "about": { "@type": "WebSite", "url": "https://rapalimus-gel.nobelpark.jp/", "name": "ラパリムスゲル 結節性硬化症 情報サイト|ノーベルファーマ" }, "variableMeasured": [ { "@type": "PropertyValue", "name": "federationId", "value": "bs-c7d51130" }, { "@type": "PropertyValue", "name": "schemaTypes", "value": "" }, { "@type": "PropertyValue", "name": "schemaCoverageScore", "value": "0.0" }, { "@type": "PropertyValue", "name": "topologyFingerprint", "value": "computed" }, { "@type": "PropertyValue", "name": "topologyModelVersion", "value": "1.0.0" }, { "@type": "PropertyValue", "name": "textLengthCategory", "value": "long" }, { "@type": "PropertyValue", "name": "typeTokenRatio", "value": "0.3544" }, { "@type": "PropertyValue", "name": "nonAsciiRatio", "value": "0.4165" }, { "@type": "PropertyValue", "name": "hapaxLegomenaRatio", "value": "0.2321" }, { "@type": "PropertyValue", "name": "javascriptSurfaceRatio", "value": "0.0" }, { "@type": "PropertyValue", "name": "navRatio", "value": "0.286" }, { "@type": "PropertyValue", "name": "securityLabel", "value": "MINIMAL" }, { "@type": "PropertyValue", "name": "freshnessLabel", "value": "STALE" }, { "@type": "PropertyValue", "name": "interiorPagesCrawled", "value": "13" }, { "@type": "PropertyValue", "name": "mintedAt", "value": "2026-07-03T14:57:01.936363+00:00" }, { "@type": "PropertyValue", "name": "specVersion", "value": "Root-LD v1.0" }, { "@type": "PropertyValue", "name": "entityType", "value": "domain" }, { "@type": "PropertyValue", "name": "detectedLanguage", "value": "" }, { "@type": "PropertyValue", "name": "hasGeo", "value": "False" }, { "@type": "PropertyValue", "name": "hasAtomicAnswer", "value": "False" } ], "root_ld": { "anchor": { "uuid": "c7d51130-e98e-4e25-9735-05404e27cbb0", "federation_id": "bs-c7d51130", "sequence": 0, "content_hash": "cc7259c1a8f1e33a08a899ce0f1968d6ba2aad506ad6425f8b4299d7ddafa041", "primary_source": "https://rapalimus-gel.nobelpark.jp/", "source_verified": true, "generation_method": "crawl_extract_v1", "spec_version": "1.0", "queued_at": "2026-05-26T20:36:55.657956+00:00", "minted_at": "2026-07-03T14:57:01.936363+00:00" }, "body": { "domain": "rapalimus-gel.nobelpark.jp", "canonical_url": "https://rapalimus-gel.nobelpark.jp/", "tld": "jp", "slug": "rapalimus-gel-nobelpark-jp", "status_code": 200, "redirect_chain": [], "response_time_ms": 5376, "ssl_valid": true, "server_header": "Apache", "title": "ラパリムスゲル 結節性硬化症 情報サイト|ノーベルファーマ", "h1": "", "meta_description": "ラパリムスゲル0.2%は、結節性硬化症（TSC）に伴う皮膚病変に対し、非侵襲的に使用できる局所投与の世界初の治療剤です。", "lang_declared": "", "schema_types": [], "schema_score": 0.0, "schema_prop_count": 0, "schema_gap_list": [], "top_semantic_words": [ "tuberous", "sclerosis", "pick", "pubmed", "complex", "topical", "nobelpharma", "sirolimus", "dermatol", "javascript", "gel", "facial", "rapamycin", "enable", "pdf", "reader", "angiofibromas", "management", "related", "analysis", "treatment", "wataya", "kaneda", "surveillance", "adobe", "efficacy", "patients", "clinical", "jama", "therapy", "medpass", "cutaneous", "manifestations", "interim", "postmarketing", "japan", "angiofibroma", "tsc", "skin", "trial" ], "ratio_signals": { "schema_density": 0.0, "nav_ratio": 0.2857, "content_to_structure_ratio": 0.069041, "external_tld_diversity": 1, "self_declaration_coherence": 0.1, "schema_to_navigation_alignment": 0.0, "javascript_surface_ratio": 0.0, "url_depth_distribution": { "depth_0": 1, "depth_1": 14, "depth_2": 9, "depth_3plus": 11 } }, "semantic_html_ratio": 0.0, "javascript_surface_ratio": 0.0, "img_alt_coverage": 0.0, "robots_complexity_score": 0, "ariadne_blocked": false, "security_label": "MINIMAL", "https_enforced": true, "freshness_label": "STALE", "tld_starjet_url": "https://boisestandard.org/registry/tld/ledger/jp", "schema_starjet_urls": [], "native_text_sample": "トップページお問合せ\n製品情報\n安全性情報\n動画ライブラリ\n資材ライブラリ\n講演会・学会情報\n文献情報\nQ&A\n\n資材ライブラリ\n特定項目製品情報概要\nTopical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan\n（結節性硬化症に伴う皮膚病変のシロリムス外用ゲル剤0.2%によるマネージメント：日本における市販後調査の中間解析）\n動画ライブラリ\n国際的なTuberousSclerosisComplex（結節性硬化症）の経過観察・管理に関する推奨2021年改訂版\n－皮膚病変の治療について－\n監修：水口 雅 先生\n　　　東京大学 名誉教授\n　　　心身障害児総合医療療育センター\n　　　むらさき愛育園 園長\n動画ライブラリ\nラパリムスゲルの健康関連QOLへの影響\n監修：波多野 孝史 先生\n　　　聖隷横浜病院 泌尿器科 部長\n", "topology_fingerprint_version": "1.0.0", "entity_type": "domain", "geo": { "address": "", "latitude": null, "longitude": null, "place_id": "", "category": "", "jurisdiction_path": "", "provenance_source": "", "fetched_at": "" }, "atomic_answer": "" }, "recursive": { "edges": [], "appended_at": [], "edge_count": 0 } }, "topology_fingerprint_summary": { "model_version": "1.0.0", "text_length_category": "long", "raw_text_length": 18151, "extracted_text_hash": "8bfb768efe6eccea1d27b6d08315530f2d07ac0671dfa32a0093f005e5c736cb", "detected_language": "", "entity_type": "domain", "type_token_ratio": 0.354374, "non_ascii_ratio": 0.416506, "character_entropy": 4.967247, "hapax_legomena_ratio": 0.232107, "hapax_to_type_ratio": 0.654979, "comma_to_period_ratio": 0.1667, "repetition_score": 0.767893 }, "schema_graph_summary": { "declared_types": [], "parent_types": [], "sibling_types": [], "child_types": [], "negative_space": [ "Action", "BioChemEntity", "CreativeWork", "Event", "Intangible", "MedicalEntity", "Organization", "Person", "Place", "Product" ] } }